epitheli
surfac
throughout
bodi
continu
sampl
respond
environment
stimuli
access
lung
epithelium
inhal
therapi
make
possibl
stimul
local
antimicrobi
defenc
aerosol
innat
immun
ligand
strategi
shown
effect
preclin
model
deliveri
innat
immun
ligand
lung
laboratori
anim
result
protect
subsequ
challeng
microbi
pathogen
surviv
anim
host
set
correl
directli
kill
pathogen
within
lung
indic
induct
resist
mechan
resist
appear
mediat
primarili
activ
epitheli
cell
rather
recruit
leucocyt
resist
reach
peak
within
hour
persist
sever
day
innat
immun
ligand
interact
synergist
circumst
synergist
combin
innat
ligand
deliv
aerosol
capabl
induc
high
level
broad
host
resist
bacteria
fungi
virus
induct
innat
antimicrobi
resist
within
lung
could
clinic
applic
prevent
lower
respiratori
tract
infect
subject
transient
high
risk
includ
cancer
patient
undergo
myeloabl
chemotherapi
intub
patient
mechan
ventil
vulner
individu
season
influenza
epidem
asthmat
subject
experienc
respiratori
viral
infect
healthi
subject
expos
virul
pathogen
bioterror
attack
emerg
pandem
summari
stimul
lung
epithelium
induc
local
resist
infect
novel
strategi
whose
clinic
util
assess
near
futur
epithelia
tradit
view
passiv
mechan
barrier
pathogen
invas
wherea
leucocyt
view
mediat
activ
antimicrobi
defenc
increas
appreci
import
innat
immun
recent
decad
led
recognit
activ
defenc
epitheli
tissu
activ
epitheli
defenc
carri
barrier
epithelia
respiratori
digest
reproduct
tract
skin
local
innat
immun
intern
epitheli
organ
vertebr
liver
insect
fat
bodi
system
innat
immun
besid
produc
antimicrobi
product
mediat
baselin
resist
microbi
infect
barrier
intern
epitheli
tissu
known
capabl
greatli
increas
antimicrobi
function
stimul
high
degre
induc
antimicrobi
epitheli
defenc
suggest
may
manipul
therapeut
promot
resist
infect
articl
focus
therapeut
induct
innat
defenc
lung
prevent
pneumonia
interest
induc
antimicrobi
defenc
aros
work
us
other
airway
mucou
metaplasia
allerg
inflamm
struck
remark
structur
plastic
epithelium
figur
indic
highli
respons
environ
evan
et
al
william
et
al
accompani
structur
chang
work
other
shown
extens
chang
lung
epitheli
cell
gene
express
figur
respons
inflammatori
stimuli
travi
et
al
knowl
boucher
martin
frevert
rogan
et
al
woodruff
et
al
zhen
et
al
sinc
infect
power
forc
shape
metazoan
evolut
structur
molecular
chang
occur
respons
inflam
structur
molecular
function
plastic
epitheli
cell
mucou
metaplasia
mous
airway
mice
sensit
ovalbumin
ova
three
intraperiton
inject
alum
adjuv
challeng
singl
ovalbumin
aerosol
exposur
three
day
ovalbumin
aerosol
mice
kill
lung
stain
alcian
blue
period
acid
schiff
reagent
stain
mucin
airway
healthi
mous
baselin
shown
left
altern
ciliat
secretori
cell
stainabl
intracellular
mucin
airway
mous
mucou
metaplasia
shown
right
secretori
cell
fill
larg
mucincontain
granul
evan
et
al
b
time
cours
specif
induct
antimicrobi
peptid
drosophila
thorax
prick
needl
injuri
needl
dip
cultur
gramneg
bacterium
e
coli
gramposit
bacterium
luteu
fungu
b
bassiana
top
row
design
time
challeng
total
rna
extract
probe
northern
blot
analysi
express
diptericin
dipt
drosocin
drom
lemaitr
et
al
c
time
cours
induct
resist
mous
lung
left
shown
surviv
mice
pretreat
steril
aerosol
lysat
nontyp
h
influenza
nthi
challeng
live
aerosol
pneumonia
sp
p
treat
vs
untreat
right
shown
bacteri
count
lung
mice
immedi
aerosol
pneumonia
clement
et
al
p
treat
vs
untreat
mation
evolv
pathogen
defenc
infer
mammalian
airway
epitheli
cell
like
possess
strong
defens
function
infer
support
work
insect
past
three
decad
show
epitheli
cell
capabl
sens
microbi
product
respond
induct
highli
effect
antimicrobi
defenc
lemaitr
et
al
medzhitov
et
al
lehrer
ganz
hoffmann
ferrandon
et
al
furthermor
insect
epitheli
respons
partial
specif
class
infect
pathogen
figur
indic
effect
inflammatori
stimulu
lung
epithelium
appropri
desir
respons
specif
type
allerg
inflamm
signal
defens
respons
parasit
worm
anthoni
et
al
wherea
type
inflamm
signal
defens
respons
intracellular
pathogen
type
inflamm
extracellular
pathogen
aujla
et
al
b
dubin
koll
figur
order
strongli
stimul
antimicrobi
defenc
administ
bacteri
lysat
aerosol
reason
would
expos
lung
epitheli
cell
microbi
product
proport
present
natur
infect
figur
result
high
level
protect
subsequ
respiratori
challeng
broad
array
bacteri
fungal
viral
pathogen
tuvim
et
al
evan
et
al
b
gener
host
util
two
contrast
strategi
surviv
infect
activ
reduct
pathogen
burden
resist
host
adapt
pathogen
virul
toler
experi
show
treatmentenhanc
host
surviv
accompani
kill
infect
pathogen
within
lung
figur
resist
mechan
indic
induct
resist
depend
upon
leucocyt
evan
et
al
recapitul
vitro
lung
epitheli
cell
stimul
bacteri
lysat
evan
et
al
indic
epitheli
cell
primarili
respons
sens
innat
stimuli
gener
antimicrobi
effector
respons
data
relat
work
other
see
indic
rather
outsourc
activ
antimicrobi
defenc
leucocyt
metazoan
evolut
epithelia
retain
capabl
activ
defenc
addit
interact
airway
epithelium
leucocyt
extern
environ
airway
epithelium
compris
mosaic
ciliat
secretori
cell
shown
overlaid
mucu
gel
shown
inhal
molecul
contact
epithelium
induc
quasispecif
innat
immun
inflammatori
respons
inhal
stimuli
includ
biolog
product
trehalos
dimycol
mycobacteria
chitin
proteas
dust
mite
parasit
lipopolysaccharid
lp
lipotecho
acid
lta
cpgrich
nucleotid
cpg
bacteria
stimuli
induc
respons
epithelium
product
nitric
oxid
antihelminth
effector
resistinlik
molecul
chitinas
antimicrobi
effector
defensin
reactiv
oxygen
speci
ro
time
respond
directli
epithelium
recruit
innat
leucocyt
macrophag
eosinophil
eo
nuocyt
neutrophil
chemokin
eotaxin
epithelium
also
recruit
adapt
immun
cell
elabor
chemoattract
thymu
activ
regul
chemokin
dendrit
cell
intercal
epithelium
sens
environment
stimuli
well
signal
releas
epithelium
thymic
stromal
lymphopoietin
tslp
travel
local
lymphoid
tissu
interact
recruit
cell
induc
differenti
helper
subset
tailor
perceiv
pathogen
cell
releas
cytokin
interferon
ifn
promot
epitheli
resist
mechan
thu
epitheli
cell
directli
sens
respond
environment
stimuli
also
signal
leucocyt
turn
reinforc
epitheli
defenc
add
defens
function
phagocytosi
acquir
abil
collabor
leucocyt
mediat
cytokin
barrier
epithelia
view
akin
militari
perimet
defenc
includ
passiv
mechan
activ
kill
compon
prevent
invas
advantag
passiv
biolog
defenc
includ
exclus
high
proport
potenti
invad
mechan
cornifi
epithelium
mucu
layer
littl
expenditur
energi
damag
host
convers
activ
defenc
incur
substanti
cost
host
injuri
reactiv
oxygen
nitrogen
radic
promot
carcinogenesi
induct
prolifer
inhibit
apoptosi
nonetheless
reduct
microbi
burden
epitheli
perimet
reduc
chanc
pathogen
invas
lead
host
death
concentr
activ
defenc
barrier
epithelia
pathogen
occur
highest
number
maxim
benefit
limit
cost
spread
defenc
evenli
throughout
host
induct
high
level
resist
microbi
infect
aerosol
bacteri
lysat
provid
proofofprincip
potenti
valu
therapeut
manipul
innat
immun
defenc
within
lung
practic
therapeut
agent
therefor
greater
understand
mechan
induc
resist
requir
develop
technolog
clinic
translat
jaw
vertebr
evolv
two
distinct
pathogen
sens
mechan
distinguish
natur
receptor
adapt
immun
util
antigen
receptor
express
b
lymphocyt
encod
somat
recombin
gene
result
immens
librari
epitop
specif
clonal
prolifer
cell
express
precis
receptor
allow
pathogenappropri
lymphocyt
respons
immunolog
memori
limit
number
pathogen
detect
individu
cell
requir
prior
exposur
pathogen
medzhitov
contrast
innat
immun
receptor
detect
conserv
molecular
featur
common
multipl
microorgan
known
pathogenassoci
molecular
pattern
pamp
germlineencod
pattern
recognit
receptor
prr
bind
pamp
allow
recognit
larg
number
differ
microorgan
boldrick
et
al
barton
medzhitov
kopp
medzhitov
kato
et
al
kapetanov
cavaillon
prr
also
identifi
host
molecul
express
respons
infect
host
molecul
modifi
cours
infect
host
molecul
known
danger
signal
dangerassoci
molecular
pattern
damp
recognit
pamp
damp
prr
lead
express
effector
molecul
involv
microbi
defenc
inflamm
modul
adapt
immun
zhang
ghosh
tolllik
receptor
tlr
first
prr
identifi
remain
best
character
kawai
akira
tlr
highli
conserv
transmembran
protein
compris
oligospecif
patternrecognit
ectodomain
multipl
leucinerich
repeat
lrr
membranespan
ahelix
receptor
tir
domain
intracellular
signal
gay
gangloff
oneil
beutler
shown
figur
pamp
detect
tlr
result
receptorspecif
recruit
cytosol
tir
adaptor
protein
combin
requir
signal
transduct
concert
one
four
other
involv
tlr
signal
tir
adaptor
kopp
medzhitov
yamamoto
et
al
kawai
akira
kapetanov
cavaillon
oneil
bowi
signal
event
util
tir
adaptor
trif
without
tram
yamamoto
et
al
kawai
akira
oneil
bowi
ten
function
tlr
describ
human
mice
express
nine
ortholog
tlr
nonfunct
found
human
gay
gangloff
beutler
kawai
akira
pcr
investig
primari
cell
immort
cell
line
indic
express
human
mous
lung
epitheli
cell
muir
et
al
schleimer
sha
et
al
gay
gangloff
bartlett
et
al
primari
ligand
coreceptor
complex
host
protein
bacteri
lipopolysaccharid
lp
facilit
detect
gramneg
pathogen
detect
lipopeptid
peptidoglycan
lipotecho
acid
atyp
lp
promot
recognit
gramposit
bacteria
parasit
gramneg
bacteria
function
heterodim
recogn
triacyl
lipopeptid
eg
recogn
diacyl
lipopeptid
eg
hereaft
fungal
zymosan
highli
conserv
motif
flagellin
found
mani
bacteri
speci
recogn
four
tlr
recogn
microbi
nucleic
acid
recogn
doublestrand
rna
stimul
synthet
copolym
poli
inosin
poli
cytosin
poli
c
tlr
detect
microbi
singlestrand
rna
contain
polyuridin
polyu
gurich
sequenc
well
imidazoquinolon
diebold
et
al
heil
et
al
recogn
dna
unmethyl
cpg
motif
number
host
danger
signal
damp
heat
shock
protein
also
ligand
tlr
kawai
akira
gay
gangloff
oneil
beutler
insight
role
tlr
defenc
pneumonia
provid
experi
tlrdefici
mice
mice
defici
show
increas
suscept
haemophilu
influenza
escherichia
coli
respiratori
syncyti
viru
pneumonia
kurtjon
et
al
wang
et
al
lee
et
al
defici
mice
increas
suscept
legionella
pneumophila
pneumonia
gribar
et
al
interestingli
mice
defici
demonstr
hypersuscept
pseudomona
aeruginosa
ramphal
et
al
although
mutat
pseudomon
flagellin
prevent
bind
impair
bacteri
clearanc
host
surviv
ramphal
et
al
defici
may
actual
confer
surviv
advantag
influenza
pneumonia
le
goffic
et
al
presum
prevent
excess
host
respons
howev
find
intranas
pretreat
agonist
protect
influenza
pneumonia
highlight
requir
precis
regul
tlrdepend
respons
microbi
defenc
wong
et
al
long
appar
microbi
product
could
stimul
inflammatori
respons
respiratori
epithelium
suspect
tlr
contribut
respons
time
first
identifi
mammal
diamond
et
al
cultur
respiratori
epitheli
cell
respond
stimul
tlr
agonist
tlrinduc
microbi
resist
detect
microbi
pamp
endogen
damp
synthet
ligand
lung
epitheli
tlr
result
receptorspecif
recruit
tir
adaptor
mal
trif
andor
tram
trifdepend
signal
activ
signal
via
tank
complex
well
activ
canon
ikk
complex
togeth
trifdepend
pathway
promot
transcript
inflammatori
mediat
type
interferon
antimicrobi
effector
via
nfkb
transloc
nucleu
signal
tlr
proce
irak
activ
tlr
activ
signal
without
lead
activ
turn
activ
complex
promot
ikk
mapkk
signal
nfkb
jnk
signal
result
transcript
inflammatori
antimicrobi
gene
direct
activ
tlr
also
result
activ
transcript
inflammatori
antimicrobi
gene
chemokin
secret
basolater
recruit
leucocyt
particip
defenc
lung
microbicid
effector
direct
apic
antimicrobi
polypeptid
oxidas
gener
ro
epithelium
util
tlrdepend
nontranscript
regul
event
kill
pathogen
activ
oxidas
damp
dangerassoci
molecular
pattern
er
endoplasm
reticulum
ikk
ikb
kinas
irak
receptorassoci
kinas
irf
interferon
regulatori
factor
jnk
cjun
ntermin
kinas
pathway
mal
also
known
tirap
tir
domain
contain
adaptor
protein
mkk
map
kinas
kinas
myeloid
differenti
primari
respons
gene
mitogenactiv
protein
map
kinas
pathway
pamp
pathogenassoci
molecular
pattern
receptorinteract
protein
ro
reactiv
oxygen
speci
tab
tgfbeta
activ
kinas
bind
protein
tank
traf
famili
memberassoci
nfkb
activ
tankbind
kinas
tir
receptor
tlr
tolllik
receptor
traf
tnf
receptor
associ
factor
tram
trifrel
adaptor
molecul
also
known
trif
tirdomaincontain
adapterinduc
interferonb
also
known
tolllik
receptor
adaptor
molecul
express
proinflammatori
antimicrobi
mediat
sha
et
al
uehara
et
al
koff
et
al
vivo
lp
administ
intranas
aerosol
protect
bacteri
fungal
lung
infect
either
enhanc
innat
defenc
attenu
lung
injuri
associ
infect
jean
et
al
empey
et
al
clement
et
al
intratrach
intraperiton
administr
cpg
oligodeoxynucleotid
odn
ligand
enhanc
surviv
lung
infect
number
pathogen
includ
mycobacterium
avium
klebsiella
pneumonia
standiford
deng
treatment
mice
agonist
induc
cytokin
product
reduc
pathogen
burden
enhanc
host
surviv
challeng
streptococcu
pneumonia
repp
et
al
mice
pretreat
poli
c
liposom
prepar
cpg
odn
display
enhanc
surviv
challeng
influenza
wong
et
al
mice
pretreat
flagellin
protect
p
aeruginosa
pneumonia
even
absenc
neutrophil
yu
et
al
addit
tlr
lung
epithelium
express
mani
nontlr
prr
sha
et
al
bartlett
et
al
evan
et
al
nucleotid
oligomer
domain
nod
like
receptor
nlr
famili
defin
protein
pampinteract
ctermin
lrr
domain
central
nucleotid
nod
one
three
ntermin
signal
domain
shaw
et
al
human
express
least
protein
restrict
leucocyt
best
studi
nlr
present
lung
epitheli
cell
uehara
et
al
shaw
et
al
unlik
tlr
nlr
cytosol
distribut
recogn
gdglutamylmesodiaminopimel
acid
present
peptidoglycan
gramneg
gramposit
bacteria
shaw
et
al
wherea
bind
muramyl
dipeptid
present
bacteri
peptidoglycan
chamaillard
et
al
activ
signal
via
result
mapk
nfkbdepend
product
proinflammatori
mediat
nlr
critic
host
respons
pneumonia
p
aeruginosa
moraxella
catarrhali
chlamydophila
pneumonia
mycobacterium
tuberculosi
lung
opitz
et
al
bartlett
et
al
divangahi
et
al
shimada
et
al
addit
nlr
includ
ipaf
naip
induc
activ
inflammasom
therebi
activ
caspas
convert
prointerleukin
il
matur
form
martinon
et
al
protein
primarili
recogn
danger
signal
includ
host
inflammatori
mediat
crystal
also
detect
product
microbi
pathogen
miao
et
al
martinon
et
al
observ
mrna
increas
lung
mice
almost
treatment
aerosol
bacteri
lysat
induc
resist
suggest
role
inflammasom
activ
furthermor
nlr
demonstr
synergist
signal
tlr
bourhi
wert
retino
acid
induc
gene
rig
ilik
receptor
rlr
cytosol
prr
involv
tlrindepend
sens
virus
associ
product
type
interferon
kawai
akira
rlr
famili
two
known
member
rigi
melanoma
differenti
associ
gene
rigi
detect
noncap
rna
hornung
et
al
allow
recognit
ssrna
virus
kawai
akira
rigidefici
mice
demonstr
impair
antivir
respons
primari
ligand
dsrna
hornung
et
al
although
also
like
detect
poli
c
tlrindepend
manner
defici
increas
suscept
sever
picornavirus
besid
innat
receptor
famili
addit
cellular
macromolecul
particip
microbi
recognit
exampl
lactosylceramid
glycosphingolipid
found
apic
surfac
lung
epitheli
cell
detect
fungal
bglucan
hahn
et
al
evan
et
al
prr
class
scaveng
receptor
eg
marco
sraiii
appear
particip
lung
defenc
express
function
lung
epithelium
unresolv
adapt
immun
signal
cytokin
interferon
also
induc
epitheli
resist
ank
paludan
billiau
matthi
identifi
critic
pathway
induc
resist
might
exploit
pharmacolog
test
mice
lack
tir
adaptor
mediat
signal
tlr
downstream
effector
absenc
trif
result
complet
loss
induct
resist
aerosol
bacteri
lysat
point
domin
role
subset
tlr
respons
stimulu
duggan
et
al
systemat
screen
avail
tlr
ligand
induct
resist
duggan
et
al
determin
efficaci
dose
elicit
neutrophil
influx
bronchoalveolar
lavag
fluid
use
evid
epitheli
stimul
even
though
neutrophil
requir
induc
resist
inflamm
character
elabor
neutrophil
chemotactin
accompani
induct
antibacteri
respons
tlr
ligand
alon
elicit
resist
respons
equal
magnitud
elicit
aerosol
bacteri
lysat
duggan
et
al
howev
prior
literatur
suggest
innat
immun
ligand
interact
synergist
activ
effector
respons
powel
et
al
merlo
et
al
trinchieri
sher
tlr
ligand
also
screen
combin
combin
class
c
oligodeoxynucleotid
odn
induc
high
level
resist
bacteri
duggan
et
al
viral
et
al
pathogen
figur
magnitud
time
cours
breadth
protect
induc
combin
odn
compar
bacteri
lysat
suggest
combin
might
serv
clinic
use
drug
initi
doseformul
identifi
base
upon
recruit
neutrophil
compon
alon
optim
doseformul
achiev
maxim
host
protect
minim
drug
exposur
concentr
compon
systemat
vari
determin
optim
doseratio
dosestrength
use
bayesian
approach
figur
b
demonstr
optim
molar
doseratio
odn
plateau
effect
mm
mm
odn
figur
doseformul
ml
nebul
solut
mm
mm
odn
use
toxic
efficaci
studi
maxim
extent
epitheli
defenc
probabl
uncov
doserespons
relationship
aerosol
bacteri
lysat
remain
formal
possibl
greater
resist
could
induc
addit
innat
immun
ligand
present
lysat
test
substanc
suppress
resist
present
lysat
fraction
lysat
substitut
purifi
innat
immun
agonist
would
result
greater
resist
howev
greater
respons
report
combin
innat
immun
agonist
plateau
benefit
observ
increas
dose
bacteri
lysat
synergist
combin
like
reflect
maxim
activ
epitheli
effector
mechan
induct
increas
resist
infect
clearli
appar
h
stimul
duggan
et
al
yu
et
al
like
resist
begin
increas
posttransl
mechan
within
minut
stimul
although
earli
time
point
yet
care
analys
resist
reach
maximum
h
stimul
accompani
extens
chang
gene
express
howev
causal
role
chang
express
specif
gene
yet
synergist
combin
tolllik
receptor
ligand
either
oligodeoxynucleotid
odn
alon
deliv
lung
aerosol
ml
induc
littl
protect
mice
left
pathogen
kill
within
lung
right
mice
challeng
h
later
pneumonia
top
p
aeruginosa
bottom
howev
combin
treatment
odn
blue
induc
greaterthanaddit
host
protect
pathogen
kill
pb
phosphat
buffer
salin
determin
small
declin
magnitud
resist
detect
h
stimul
virul
microbi
challeng
use
duggan
et
al
detect
small
differ
host
surviv
strong
weak
challeng
akin
uncov
small
differ
agonist
efficaci
tissu
tachyphylaxi
use
function
antagon
biochem
physiolog
endpoint
use
tradit
pharmacolog
studi
johnson
booth
et
al
dryden
et
al
induc
resist
continu
slowli
declin
time
stimul
consist
detect
day
detect
decreas
magnitud
induc
resist
repetit
dose
everi
day
seven
dose
evan
et
al
make
teleolog
sens
epitheli
barrier
lessen
defenc
long
signal
indic
microbi
threat
persist
surpris
tachyphylaxi
inflamm
accompani
induct
resist
moghaddam
et
al
howev
result
consist
work
macrophag
found
tachyphylaxi
inflammatori
antimicrobi
gene
express
chang
repetit
exposur
innat
immun
ligand
medzhitov
togeth
find
excit
point
prospect
resist
inflamm
resolv
least
partial
rais
possibl
therapeut
benefit
minim
side
effect
stimul
lung
epithelium
innat
immun
ligand
induc
antimicrobi
resist
accompani
vigor
inflammatori
respons
character
elabor
numer
chemokin
cytokin
infiltr
lung
tissu
neutrophil
leucocyt
howev
leucocyt
extracellular
signal
molecul
shown
necessari
induct
resist
furthermor
dissoci
inflammatori
signal
induct
resist
indic
fall
cytokin
level
back
toward
baselin
resist
even
reach
maximum
moghaddam
et
al
tuvim
et
al
tachyphylaxi
occur
inflamm
resist
thu
resist
inflamm
often
associ
recruit
mediat
leucocyt
system
circul
clearli
help
clearanc
infect
resist
synonym
inflamm
optim
induct
resist
within
lung
accompani
inflamm
airway
fibrosi
promot
epitheli
carcinogenesi
moghaddam
et
al
howev
effect
dissoci
resist
phenomenon
must
distinguish
specif
particular
ligand
deliveri
system
exampl
may
possibl
identifi
ligand
maxim
induct
resist
minim
induct
inflamm
administ
drug
suppress
inflamm
togeth
one
induc
resist
importantli
inflamm
mostli
confin
lung
lumen
littl
system
inflamm
tuvim
et
al
evan
et
al
therefor
inflamm
may
seriou
side
effect
aerosol
innat
immun
ligand
system
administr
immunomodulatori
drug
suntharalingam
et
al
although
requir
care
clinic
studi
similarli
airway
fibrosi
result
prolong
repetit
exposur
bacteri
lysat
week
probabl
requir
adapt
immun
respons
protein
compon
lysat
could
avoid
use
synthet
innat
immun
ligand
moghaddam
et
al
also
requir
investig
much
remain
learn
inhal
pharmaceut
gener
inhal
immunomodulatori
compound
particular
patton
et
al
contrast
side
effect
might
dissoci
resist
promot
lung
carcinogenesi
like
intrins
properti
induct
resist
activ
antiapoptot
epitheli
repair
pathway
parallel
antimicrobi
pathway
houghton
et
al
moghaddam
et
al
therefor
side
effect
may
limit
durat
treatment
induc
microbi
resist
particularli
among
subject
prone
harbour
oncogen
epitheli
mutat
chronic
cigarett
smoker
yet
known
whether
stimul
alveolar
epitheli
cell
requir
togeth
stimul
airway
epitheli
cell
effect
induc
resist
within
lung
target
deliveri
innat
immun
ligand
conduct
airway
alon
control
aerosol
droplet
size
could
minim
alveolar
inflamm
might
compromis
ga
exchang
hyperrespons
bronchoconstrictor
stimuli
featur
allerg
inflamm
unlik
accompani
induct
antimicrobi
resist
possibl
assess
knowledg
innat
immun
ligand
receptor
effect
induc
resist
within
lung
identifi
adaptor
protein
transcript
factor
involv
signal
pathway
downstream
receptor
implic
bal
hiemstra
bartlett
et
al
beutler
necessari
suffici
antimicrobi
effector
respons
yet
know
certainti
detail
effector
like
combin
oxid
antimicrobi
peptid
act
synergist
induc
microbi
kill
addit
efficaci
ligand
receptor
probabl
identifi
may
involv
pathway
effector
role
subset
lung
epitheli
cell
need
delin
continu
activ
area
basic
investig
could
lead
improv
pharmacolog
properti
therapi
introduc
clinic
possibl
envis
sever
scenario
deliveri
innat
immun
ligand
lung
induc
resist
microbi
infect
could
use
cancer
patient
undergo
myeloabl
chemotherapi
highli
suscept
bacteri
fungal
pneumonia
week
period
profound
neutropenia
lung
epitheli
cell
turn
slowli
contrast
gut
epitheli
cell
neutrophil
less
suscept
acut
effect
cytotox
chemotherapi
bowden
rawlin
et
al
rawlin
hogan
rock
et
al
stimul
lung
epithelium
aerosol
innat
immun
ligand
everi
day
period
vulner
could
reduc
incid
pneumonia
might
allow
intens
chemotherapi
increas
chanc
cure
underli
malign
organ
transplant
patient
subject
undergo
immunosuppress
might
similarli
benefit
transient
induct
innat
antimicrobi
resist
within
lung
intub
patient
mechan
ventil
intens
care
unit
high
risk
nosocomi
pneumonia
rate
ventilatorassoci
pneumonia
might
reduc
treatment
aerosol
innat
immun
ligand
princip
caus
asthma
exacerb
respiratori
viral
infect
rosenth
et
al
degre
reflect
impair
viral
clearanc
excess
type
respons
viru
yet
known
nonetheless
limit
viral
spread
within
lower
respiratori
tract
treatment
aerosol
innat
immun
ligand
could
benefici
addit
possibl
therapeut
deviat
immun
respons
away
excess
type
respons
normal
peopl
could
benefit
expos
pathogen
high
virul
set
bioterror
attack
emerg
infect
avian
influenza
sever
acut
respiratori
syndrom
viru
vaccin
becom
avail
airway
epithelium
capabl
directli
sens
microbi
product
indirectli
sens
pathogen
cytokin
mediat
releas
host
cell
stimuli
induc
power
epitheli
antimicrobi
respons
result
high
level
resist
microbi
infect
pharmacolog
manipul
pathway
inhal
deliveri
agonist
may
use
therapeut
protect
vulner
popul
pneumonia
